Cantor Fitzgerald reaffirmed its Overweight rating and $14.00 price target for Skye Bioscience shares, traded on NASDAQ: SKYE. This target sits at the lower end of the analyst range, with InvestingPro ...
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback